Featured Research

from universities, journals, and other organizations

Common Antacids Could Help Keep Gingivitis At Bay

Date:
November 6, 2006
Source:
University of Rochester Medical Center
Summary:
Chemicals commonly used to treat heartburn also display fighting power against the oral bacteria linked with gum disease, according to researchers at the University of Rochester Medical Center and Göteborg University in Sweden.

Chemicals commonly used to treat heartburn also display fighting power against the oral bacteria linked with gum disease, according to researchers at the University of Rochester Medical Center and Göteborg University in Sweden.

Related Articles


A study published in November's Archives of Oral Biology explores how the active ingredients in popular antacids could help fend off gingivitis. If the work holds up in subsequent studies in people, the compounds could one day find themselves widely available in oral care products like toothpaste and mouthwashes.

"The American diet and the constant drip of sugar allows little time for the natural repair of teeth. All day, it's a cycle of acidic erosion and repair -- or at least, it should be -- but our constant sucking on hard candy and guzzling sodas with high fructose syrups leaves little time for repair," said Robert Marquis, Ph.D., of the University of Rochester Medical Center. Marquis, an internationally recognized expert on the bacteria that inhabit our mouths, is the study's lead author.

The team studied a compound known as lansoprazole, part of a family of compounds known as benzimidazoles that already have a range of uses, primarily controlling stomach hyperacidity and killing Helicobacter pylori (the bacteria responsible for stomach ulcers). Now, the compounds are brandishing potent antimicrobial actions that interfere with the dirty work of other types of bacteria that cause plaque buildup and gingivitis.

Such bacteria make their home on unbrushed teeth, which become coated with plaque, a filmy substance that, under a microscope, appears as a teeming sea of hundreds of bacteria. Among these are gingivitis-causing bacteria that break down sugars and amino acids into toxins that are harmful to our gums.

Unchecked, an accumulation of plaque and an overgrowth of these ravenous, toxin-oozing bacteria leads to one of the body's natural immune responses, inflammation, where bacteria-fighting cells are recruited to the gums to fight off the infection. Unfortunately, instead of just fending off the bacteria, the immune response also inflicts damage to the healthy gums. In the case of an intense infection, the battle drags out and results in more devastation to the gums, or gingivitis.

Since gingivitis can be a preamble for periodontal disease -- an oral inflammation so persistent that it destroys the bone where the teeth anchor, causing them to fall out -- researchers at the University of Rochester and Göteborg University in Sweden decided to focus on Fusobacterium nucleatum, an especially hardy bacterial troublemaker that plays a crucial role in setting the stage for gum disease.

When it's not secreting irritating chemicals itself, F. nucleatum acts as a binding site for other dangerous oral bacteria that cannot directly attach to tooth surfaces on their own. These bacteria, dubbed "secondary colonizers," rely on the help of F. nucleatum, which serves almost like an aircraft landing strip atop an aircraft carrier, allowing planes (or in this case, bacteria) to set down. With the help of F.nucleatum, these dangerous bacteria now have a place to "land" and create the damage that causes periodontal disease and tooth decay.

"It acts as a transitional organism, welcoming the bacteria which couldn't survive there on their own, and moving the infection from above the gum line to below it," said Marquis, professor of both Microbiology & Immunology and Oral Biology.

That's where lansoprazole comes in. When the oral environment becomes acidic -- a telltale sign of bacteria at work -- lansoprazole is chemically modified to kick into action, disabling F. nucleatum and preventing it from producing toxins or serving as a landing site. Once the oral environment returns to normal, the lansoprazole simply switches off.

"Benzimidazoles aren't just for acid-reflux anymore," said Marquis, whose research project was supported by the National Institute of Dental and Craniofacial Research. "We've shown their promise for preventing cavities in previous research, and now, perhaps even some protective benefits to guard against gingivitis. It's not unthinkable that one day these compounds might be more broadly used to promote dental health in toothpastes and mouthwashes."


Story Source:

The above story is based on materials provided by University of Rochester Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

University of Rochester Medical Center. "Common Antacids Could Help Keep Gingivitis At Bay." ScienceDaily. ScienceDaily, 6 November 2006. <www.sciencedaily.com/releases/2006/11/061103083711.htm>.
University of Rochester Medical Center. (2006, November 6). Common Antacids Could Help Keep Gingivitis At Bay. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/2006/11/061103083711.htm
University of Rochester Medical Center. "Common Antacids Could Help Keep Gingivitis At Bay." ScienceDaily. www.sciencedaily.com/releases/2006/11/061103083711.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins